ths and for children aged 24-59 months who are at increased risk for pneumococcal disease (e.g., children with anatomic or functional asplenia, sickle cell disease (SCD), HIV infection or other immunocom??promising condition, or chronic illness including chronic heart or lung disease, cerebrospinal fluid leaks, and diabetes mellitus).[11] In 2007, the ACIP revised its recommendation for routine us